Literature DB >> 25142921

Targeted therapy in lung cancer: survival, quality of life improved for some patients.

Carrie Printz.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25142921     DOI： 10.1002/cncr.28943

Source DB:  PubMed          Journal:  Cancer        ISSN： 0008-543X            Impact factor:   6.860


× No keyword cloud information.
  3 in total

1.  [Analysis of Clinical Characteristics of Lung Cancer Combined with 
Multiple Primary Malignancies in Other Organs].

Authors:  Shuai Zhang; Zhiyun Xu; Gaochao Dong; Ming Li; Lin Xu
Journal:  Zhongguo Fei Ai Za Zhi       Date:  2021-01-20

2.  Treating with Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitors (TKIs) Accompanying Lower Incidence of Second Primary Cancers.

Authors:  Wen-Ru Chou; Ben-Chang Shia; Yen-Chun Huang; Chieh-Wen Ho; Mingchih Chen
Journal:  J Clin Med       Date:  2022-09-04       Impact factor: 4.964

3.  Gefitinib induces lung cancer cell autophagy and apoptosis via blockade of the PI3K/AKT/mTOR pathway.

Authors:  Zhong-Quan Zhao; Zhong-Yang Yu; Jie Li; Xue-Nong Ouyang
Journal:  Oncol Lett       Date:  2016-05-18       Impact factor: 2.967
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.